about
Targeted laser ablation of the zebrafish larval heart induces models of heart block, valvular regurgitation, and outflow tract obstructionInhibition of the purinergic P2X7 receptor improves renal perfusion in angiotensin-II-infused rats.Effect of P2X4 and P2X7 receptor antagonism on the pressure diuresis relationship in rats.Heart on a plate: histological and functional assessment of isolated adult zebrafish hearts maintained in cultureSpatially coordinated dynamic gene transcription in living pituitary tissue.ER stress and basement membrane defects combine to cause glomerular and tubular renal disease resulting from Col4a1 mutations in mice.Effects of Cyclin Dependent Kinase 9 inhibition on zebrafish larvaeRenal disease pathophysiology and treatment: contributions from the rat.Role of Estrogen Response Element in the Human Prolactin Gene: Transcriptional Response and TimingBimodal dynamics of granular organelles in primary renin-expressing cells revealed using TIRF microscopy.Conditional Deletion of Hsd11b2 in the Brain Causes Salt Appetite and Hypertension.Hypertension fails to disrupt white matter integrity in young or aged Fisher (F44) Cyp1a1Ren2 transgenic ratsAcute inhibition of NCC does not activate distal electrogenic Na+ reabsorption or kaliuresis.Human kidney pericytes produce renin.Early-life perturbations in glucocorticoid activity impacts on the structure, function and molecular composition of the adult zebrafish (Danio rerio) heart.Physiological roles of glucocorticoids during early embryonic development of the zebrafish (Danio rerio).Controlled hypertension induces cerebrovascular and gene alterations in Cyp1a1-Ren2 transgenic rats.Temporal cohesion of the structural, functional and molecular characteristics of the developing zebrafish heart.Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes.Tight blood glycaemic and blood pressure control in experimental diabetic nephropathy reduces extracellular matrix production without regression of fibrosisCopper Catalysis in Living Systems and In Situ Drug Synthesis
P50
Q27306780-CD7C1888-E777-492D-A43D-DB9FD8F1DBB7Q30384751-5C591E80-866B-4D5F-A45B-A18B5F50153BQ30447718-117061DA-9D65-4C2E-8BDD-38002F0C169BQ33604534-6C6D5B5E-1472-4A6F-960A-E17CAD489078Q34511589-92C55712-52B2-484D-87AA-B541BBA10125Q36627721-62027CE0-CE40-46FC-8E0D-C05B237B808BQ37467587-3757A5BA-3B8E-4ABF-B80C-A237BAC64632Q37545416-F7F17519-2EA4-4C7C-BDEF-DB21C9E35300Q38809955-CD4A5F85-6AAE-46B9-A032-1B764ECF7FFAQ39030669-18CAB039-D6C7-41B4-A8E7-F264279CB40BQ39842428-725171D8-D83B-4C33-BEF8-886AD22F4D69Q40515034-C37D0822-56EE-4A15-846A-EE2EA8298ABCQ41943037-30C1C808-EC9C-4B3B-BDD2-D028344E9298Q42023597-7CD45351-1FEA-471C-B5CE-054925D0B468Q43130169-2E98C5CF-D7AB-4D61-952A-0671670A856DQ47073516-5E1BDFB2-68A2-4438-915B-F8B442E954F1Q48939126-2E0006FC-A0B3-46DD-8826-CCD5B35D0BACQ50581594-D864055D-BE7B-43D0-9047-A2ECF27C88F9Q55025398-A0F5F7B7-9373-4CB6-9D06-72FAC8816DDBQ85265733-B6A21B8F-237E-4F92-8C65-F349C432B5B4Q88791088-EBA2974F-72C6-4C6E-958C-6465378F8902
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
John Mullins
@ast
John Mullins
@en
John Mullins
@es
John Mullins
@nl
John Mullins
@sl
type
label
John Mullins
@ast
John Mullins
@en
John Mullins
@es
John Mullins
@nl
John Mullins
@sl
prefLabel
John Mullins
@ast
John Mullins
@en
John Mullins
@es
John Mullins
@nl
John Mullins
@sl
P106
P21
P31
P496
0000-0001-5745-5258